N/A
N=59
Information Visualizations to Facilitate HIV-related Patient-provider Communication (Info Viz: HIV)
Health Communication
Bottom Line
View on ClinicalTrials.gov: NCT03616106 ↗Enrolled (actual)
59
Serious AEs
0.0%
Results posted
Sep 2020
Primary outcome: Primary: Association Between Mean CD4 Count at Baseline and 3-month Visit — 385.86; 373.69 cells/mm^3 — p=0.859
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Infographic intervention (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Columbia University
- Primary completion
- Aug 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Association Between Mean CD4 Count at Baseline and 3-month Visit |
385.86; 373.69 | 0.859 |
| PRIMARY Association Between Mean CD4 Count at Baseline and 6-month Visit |
385.86; 414.41 | 0.213 |
| PRIMARY Association Between Mean CD4 Count at Baseline and 9-month Visit |
385.86; 445.42 | 0.031 sig |
| PRIMARY Association Between Mean Viral Load at Baseline and at 3-month Visits |
84,326; 81,470 | 0.053 |
| PRIMARY Association Between Mean Viral Load at Baseline and at 6-month Visits |
84,326; 91,590 | 0.008 sig |
| PRIMARY Association Between Mean Viral Load at Baseline and at 9-month Visits |
84,326; 45,581 | 0.000 sig |
| SECONDARY Satisfaction With Care Scale Score |
18.04; 18.52; 18.49; 18.31 | — |
| SECONDARY Medication Adherence |
9; 41; 0; 24; 22; 4 | — |
| SECONDARY Participant's Self-reported Health-related Quality of Life Score - Physical Functioning |
55.37; 57; 56.2; 56.64 | — |
| SECONDARY Participants' Self-reported Health Status Over Past 4 Weeks. |
7; 8; 16; 16; 1; 2 | — |
| SECONDARY Health Literacy |
18 | — |
| SECONDARY Percent of Participants Who Complete an In-depth Qualitative Interview |
52 | — |
| SECONDARY Participant's Self-reported Health-related Quality of Life Score - Anxiety |
54.09; 44.33; 46.23; 42.5 | — |
| SECONDARY Participant's Self-reported Health-related Quality of Life Score - Depression |
53.40; 45.51; 45.27; 43.19 | — |
| SECONDARY Participant's Self-reported Health-related Quality of Life Score - Fatigue |
42.46; 38.06; 36.38; 34.76 | — |
| SECONDARY Participant's Self-reported Health-related Quality of Life Score - Sleep Disturbance |
45.37; 40.60; 41.70; 43.54 | — |
| SECONDARY Participant's Self-reported Health-related Quality of Life Score - Social Activity Participation |
60.91; 63.65; 63.83; 63.72 | — |
| SECONDARY Participant's Self-reported Health-related Quality of Life Score - Pain Interference |
46.11; 42.52; 42.88; 43.59 | — |
| SECONDARY Satisfaction With Provider Scale Score at Each Time Point |
26.96; 27.69; 27.49; 27.64 | — |
| SECONDARY Association Between Mean HIV-related Knowledge Scores at Baseline and 3-month Visits. |
10.26; 12.43 | 0.000 sig |
| SECONDARY Association Between Mean HIV-related Knowledge Scores at Baseline and 6-month Visits. |
10.26; 13.14 | 0.000 sig |
| SECONDARY Association Between Mean HIV-related Knowledge Scores at Baseline and 9-month Visits. |
10.26; 13.44 | 0.000 sig |
| SECONDARY Association of Engagement With Clinician Scale Score at Baseline and 3-months. |
13; 13 | 0.0011 sig |
| SECONDARY Association of Engagement With Clinician Scale Score at Baseline and 6-months. |
13; 13 | 0.0001 sig |
| SECONDARY Association of Engagement With Clinician Scale Score at Baseline and 9-months. |
13; 13 | 0.000 sig |
| SECONDARY Association Between SEMCD Scale Score at Baseline and 3-month Visits |
7.16; 9.07 | 0.000 sig |
| SECONDARY Association Between SEMCD Scale Score at Baseline and 6-month Visits |
7.16; 9.27 | 0.000 sig |
| SECONDARY Association Between SEMCD Scale Score at Baseline and 9-month Visits |
7.16; 9.7 | 0.000 sig |
| SECONDARY Association Between Current Self-reported Health Status as Reported at Baseline and 3-months |
90; 90 | 0.1167 |
| SECONDARY Association Between Current Self-reported Health Status as Reported at Baseline and 6-months |
90; 95 | 0.0036 sig |
| SECONDARY Association Between Current Self-reported Health Status as Reported at Baseline and 9-months |
90; 98 | 0.0004 sig |
Summary
To complete the study aims, a mixed methods study that includes a single group pretest-posttest study design will be used to pilot test the infographic intervention. In-depth interviews will be completed with a selection of participants to explore participant perceptions of HIV-related communication using infographics. Data will be collected from participants through baseline (at enrollment) and follow up assessments (at 3-, 6-, and 9-month follow up visits). Follow up interviews will be conducted with the providers involved in the intervention to ascertain their perspectives on the clinical utility of infographics.
Eligibility Criteria
Inclusion Criteria
- Adult (≥) 18 years of age
- Spanish-speaking
- Living with HIV and have a detectable viral load
- Attend Clínica de Familia La Romana
- Plan to receive care at the same clinic for the next year
Exclusion Criteria
- Does not meet inclusion criteria
- Not able to understand study procedures or provide informed consent
Data sourced from ClinicalTrials.gov (NCT03616106). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.